Candesartan vs Palivizumab

## Candesartan vs Palivizumab: Overview

This comparison examines the pharmacological differences between **Candesartan** and **Palivizumab**.

## Mechanism of Action

**Candesartan**: Prodrug hydrolyzed to active form; selective angiotensin II type 1 receptor blocker.

## Pharmacokinetics

**Half-life**: Candesartan — 9 hours; Palivizumab — N/A.

## Chemical Properties

**Molecular Formula**: Candesartan — C33H34N6O6; Palivizumab — N/A.

**Molecular Weight**: Candesartan — 610.6640 g/mol; Palivizumab — N/A.

**Type**: Candesartan — Small molecule; Palivizumab — Antibody.